title: Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy.
authors.affiliation: Department of Nephrology, Pitié-Salpêtrière Hospital, Paris, France. hassan.izzedine@psl.ap-hop-paris.fr
authors.forename: Hassane
authors.initials: H
authors.lastname: Izzedine
authors.forename: Vincent
authors.initials: V
authors.lastname: Launay-Vacher
authors.forename: Magali
authors.initials: M
authors.lastname: Ciroldi
authors.forename: Laurence
authors.initials: L
authors.lastname: Fardet
authors.forename: Gilbert
authors.initials: G
authors.lastname: Deray
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000437:Alcoholism; D003511:Cyclohexanols / Q000009:adverse effects*; D005199:Fanconi Anemia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride